Trial Profile
pre-emptive therapy of interferon alpha-2b and decitibine in leukemia patients with relapsing tendencies after allogeneic hematopoietic stem cell transplantation: a prospective randomized controlled clinical study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Decitabine (Primary) ; Interferon alpha-2b (Primary)
- Indications Leukaemia
- Focus Therapeutic Use
- 28 Apr 2016 New trial record